Cynatratoside A
cynatratoside A
CAS: 97399-96-7
Molecular Formula: C28H40O8
Cynatratoside A - Names and Identifiers
Cynatratoside A - Physico-chemical Properties
| Molecular Formula | C28H40O8 |
| Molar Mass | 504.62 |
| Density | 1.27±0.1 g/cm3(Predicted) |
| Melting Point | 237-239℃ (methanol chloroform ) |
| Boling Point | 676.5±55.0 °C(Predicted) |
| pKa | 13.55±0.70(Predicted) |
| Storage Condition | 2-8℃ |
Cynatratoside A - Introduction
cynatratoside A (cynatoside A) is A natural compound derived from Mikania micrantha (Cynara scolymus). It is a glycoside compound containing such ingredients as cynatratoside alkaloids and cynatratoside glucosides.
cynatratoside A has A variety of pharmacological activities, including antioxidant, anti-inflammatory, antibacterial, anti-tumor and promoting bile secretion. Studies have shown that it may have therapeutic potential for diseases such as cardiovascular disease, cancer and inflammation.
cynatratoside A is generally prepared by extracting it from Mikania micrantha and chemically purifying it to obtain high-purity compounds. Extraction methods are commonly used to extract with an organic solvent, such as ethyl acetate or methanol, followed by purification by techniques such as chromatography.
Regarding safety, the toxicity studies of cynatratoside A are currently limited, so there is A lack of comprehensive understanding of its potential toxicity and safety. However, from the current study, cynatratoside A is considered to be relatively safe within A range of doses. However, individual tolerance to this substance may vary, so caution is required during use. Before using this compound, you should consult your doctor or professional pharmacist for advice and follow the correct method of use and dosage.
cynatratoside A has A variety of pharmacological activities, including antioxidant, anti-inflammatory, antibacterial, anti-tumor and promoting bile secretion. Studies have shown that it may have therapeutic potential for diseases such as cardiovascular disease, cancer and inflammation.
cynatratoside A is generally prepared by extracting it from Mikania micrantha and chemically purifying it to obtain high-purity compounds. Extraction methods are commonly used to extract with an organic solvent, such as ethyl acetate or methanol, followed by purification by techniques such as chromatography.
Regarding safety, the toxicity studies of cynatratoside A are currently limited, so there is A lack of comprehensive understanding of its potential toxicity and safety. However, from the current study, cynatratoside A is considered to be relatively safe within A range of doses. However, individual tolerance to this substance may vary, so caution is required during use. Before using this compound, you should consult your doctor or professional pharmacist for advice and follow the correct method of use and dosage.
Last Update：2024-04-09 21:54:55
Supplier List
Product Name: cynatratoside A Visit Supplier Webpage Request for quotation
CAS: 97399-96-7
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
CAS: 97399-96-7
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
Product Name: cynatratoside A Visit Supplier Webpage Request for quotation
CAS: 97399-96-7
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
CAS: 97399-96-7
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
View History